吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 26 2018

Full Issue

Trendy Startups Are Raring To Ride Telemedicine Wave, But Reality Putting Damper On Enthusiasm

Murky state regulations, patients desperate for medication who deceive doctors about their symptoms, and state-level infectious disease agencies and public health departments that have made clear they don鈥檛 accept certain information by email are just some of the problems these new startups face.

The first thing you see when you enter Lemonaid Health鈥檚 offices is a dazzling bright yellow accent wall. Doctors work at desks clustered together in an open-plan office, ducking into smaller offices to conduct video visits with patients. The engineering, design, and data science teams sit just steps away. Hanging from a standing coat rack is a king鈥檚 crown, like the kind found in a child鈥檚 dress-up drawer, that employees wear proudly on their work anniversary. (Robbins, 4/26)

In 2016, executives at the buzzy telemedicine startup Nurx spoke openly about their ambitions. By the following year, the company鈥檚 online services for birth control and the HIV prevention pill would be available in all 50 states. That never happened. Today, Nurx operates in just 17 states and Washington D.C. Nurx is part of a new wave of businesses that have attracted lots of excitement and investment for an idea that seems intuitive: Allowing patients to use online forms and chat messages to quickly get prescription drugs to treat simple conditions like urinary tract infections, erectile dysfunction, and hair loss. (Robbins, 4/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, August 6
  • Wednesday, August 5
  • Tuesday, August 4
  • Monday, August 3
  • Friday, July 31
  • Thursday, July 30
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF